PT  - JOURNAL ARTICLE
AU  - Ramos, Willy
AU  - Oyola-García, Alfredo Enrique
AU  - Aguirre, Aida
AU  - De la Cruz-Vargas, Jhony A.
AU  - Luna, Miguel
AU  - Alarcón, Tania
AU  - Meléndez, Mónica
AU  - Huaccho-Rojas, Juan
AU  - Cóndor-Rojas, Yudy Cley
TI  - Time analysis of dengue deaths that occurred in two regions of Peru during the climatic-atmospheric phenomena El Niño Costero and Cyclone Yaku
AID  - 10.1101/2024.03.18.24304491
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.03.18.24304491
4099  - http://medrxiv.org/content/early/2024/03/19/2024.03.18.24304491.short
4100  - http://medrxiv.org/content/early/2024/03/19/2024.03.18.24304491.full
AB  - OBJECTIVE To perform a dengue-related death time analysis that occurred in Piura and Ica (Peru) during the atmospheric phenomena of El Niño Costero and Cyclone Yaku in 2023.MATERIAL AND METHODS A case-series study was performed. We included the deaths between January 1 and June 3, 2023. We reviewed the research data base of the deaths as well as the clinical epidemiology records, death certificates and laboratory test results. A time analysis was performed from the date of onset of symptoms, date of first visit at a health establishment, date that dengue diagnosis was first registered and date of death.RESULTS We included 40 deaths by dengue in the study. 70% were females, the median age of death was 51 years of age, and 70% came from Piura. 51.2% presented some comorbidity and 14% had self-medicated with metamizole, other NSAIDS or corticoids before the initial medical consultation. 37.5% presented an unconventional clinical pattern at admission and dengue was not suspected in 40% during the initial assessment. The median time until the initial assessment, the diagnosis time, and the time from diagnosis until death were 3 days, 0 days, and 1 day, respectively. Adults presented a time until the initial assessment significantly greater than the other age groups (p=0.048), the diagnosis time was significantly less than those seen at the Health Department establishments and regional government establishments (MINSA/GORE) than in private establishments (p=0.014) and greater in pediatrics (p=0.018). The time from diagnosis until death was significantly less in those that self-medicated before the initial assessment (p=0.041).CONCLUSION The adults presented a significantly greater time until the initial assessment; the diagnosis time was less than those seen in MINSA/GORE establishments and greater in pediatrics, furthermore, the time from diagnosis until death was significantly less in those who self-medicated before the initial assessment. An important fraction of deaths presented comorbidities and an unconventional clinical pattern at admission, with dengue frequently not suspected during the initial assessment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors did not receive financial support for this article's research, authorship, and/or publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research was approved by the Research Ethics Committee of the Ricardo Palma University, School of Medicine (Expedited Review: PI-010-2023).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData may be made available by contacting the corresponding author.